GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Yunkang Group Ltd (HKSE:02325) » Definitions » Equity-to-Asset

Yunkang Group (HKSE:02325) Equity-to-Asset : 0.47 (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Yunkang Group Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Yunkang Group's Total Stockholders Equity for the quarter that ended in Jun. 2024 was HK$2,065.1 Mil. Yunkang Group's Total Assets for the quarter that ended in Jun. 2024 was HK$4,381.8 Mil. Therefore, Yunkang Group's Equity to Asset Ratio for the quarter that ended in Jun. 2024 was 0.47.

The historical rank and industry rank for Yunkang Group's Equity-to-Asset or its related term are showing as below:

HKSE:02325' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.47   Med: 0.54   Max: 0.63
Current: 0.47

During the past 6 years, the highest Equity to Asset Ratio of Yunkang Group was 0.63. The lowest was 0.47. And the median was 0.54.

HKSE:02325's Equity-to-Asset is ranked worse than
63.6% of 228 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.585 vs HKSE:02325: 0.47

Yunkang Group Equity-to-Asset Historical Data

The historical data trend for Yunkang Group's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yunkang Group Equity-to-Asset Chart

Yunkang Group Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial 0.61 0.54 0.59 0.52 0.47

Yunkang Group Semi-Annual Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.63 0.52 0.50 0.47 0.47

Competitive Comparison of Yunkang Group's Equity-to-Asset

For the Diagnostics & Research subindustry, Yunkang Group's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yunkang Group's Equity-to-Asset Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Yunkang Group's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Yunkang Group's Equity-to-Asset falls into.



Yunkang Group Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Yunkang Group's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=2310.227/4957.063
=0.47

Yunkang Group's Equity to Asset Ratio for the quarter that ended in Jun. 2024 is calculated as

Equity to Asset (Q: Jun. 2024 )=Total Stockholders Equity/Total Assets
=2065.089/4381.773
=0.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Yunkang Group  (HKSE:02325) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Yunkang Group Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Yunkang Group's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Yunkang Group Business Description

Traded in Other Exchanges
N/A
Address
No. 6 Yayingshi Road, Science City, Huangpu District, Guangzhou, CHN
Yunkang Group Ltd is a medical operation service provider in China. The company has three major business lines namely covering diagnostic testing services for medical consortia, diagnostic outsourcing services, and non-medical institutions.
Executives
Huizekx Limited 2201 Interest of corporation controlled by you
Yk Development Limited 2101 Beneficial owner
Zhang Yong 2201 Interest of corporation controlled by you
Shanghai Pudong Development Bank Co., Ltd 2201 Interest of corporation controlled by you
Zhou Xinyu
Guang Zhou Da An Ji Yin Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you
Da An Guo Ji Ji Tuan You Xian Gong Si 2101 Beneficial owner
Guang Zhou Shi Da An Ji Yin Ke Ji You Xian Gong Si 2201 Interest of corporation controlled by you
Jin Jun Ying Limited 2201 Interest of corporation controlled by you
Mouduans Limited 2201 Interest of corporation controlled by you
Source Capital Rw Limited 2201 Interest of corporation controlled by you
Tongfuzc Limited 2201 Interest of corporation controlled by you
Wjjr Investment Limited 2201 Interest of corporation controlled by you

Yunkang Group Headlines

No Headlines